4//SEC Filing
Kim Dong 4
Accession 0001437749-23-002340
CIK 0001668243other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 1:05 PM ET
Size
7.2 KB
Accession
0001437749-23-002340
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2023-01-31+10,000→ 10,000 total→ Ordinary Shares (10,000 underlying) - Award
Employee Stock Option (right to buy)
2023-01-31+38,000→ 38,000 totalExercise: $10.39Exp: 2033-01-31→ Ordinary Shares (38,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
- [F3]1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001920163
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 1:05 PM ET
- Size
- 7.2 KB